Skip to main content
. Author manuscript; available in PMC: 2019 May 29.
Published in final edited form as: Nucl Med Biol. 2008 Aug;35(6):673–678. doi: 10.1016/j.nucmedbio.2008.05.003

Fig. 3.

Fig. 3.

Cell viability studies: Decreased cell viability of human pancreatic adenocarcinoma Capan-2 cells from Cohort 2 when treated with sstr-targeted 177Lu-DOTATOC after 24 h (A) and 48 h (B) incubation. The data are expressed as mean±S.E.M. (n≥3).